Lansoprazole (Lansoprazole) Patent Expiration, LOE Window & CMS Spending

Lansoprazole (Lansoprazole) by Dexcel Technologies: FDA Orange Book LOE 2036-04-21, 5 AB generics, $60.2M 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorDexcel Technologies
FDA Application & PathwayN208025 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2036-04-21
Orange Book Patents (*PED Extensions)2 patents (0 *PED)
Active AB-Rated Generic Competitors5
2024 CMS Total Public Spend$60.2M
2024 Medicare Part D Spend$47.3M
2024 Medicaid Spend$12.9M
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel